Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bernstein

Showing results (431-440 of 728) with videos related to

Pageof 73
Sort By:
Bone Marrow Transplantation|June 12, 2002
The use of radioimmunoconjugates in stem cell transplantationJ M Pagel, D C Matthews, F R Appelbaum, et al.
The International Journal of the Addictions|March 1, 1995
Methods for assessing drug use prevalence in the workplace: a comparison of self-report, urinalysis, and hair analysisR F Cook, A D Bernstein, T L Arrington, et al.
Cancer Treatment and Research|January 1, 1997
The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignanciesD C Matthews, F R Appelbaum, O W Press, et al.
AJNR. American Journal of Neuroradiology|May 1, 1983
Intravenous digital subtraction angiography with iohexolE D Cacayorin, A D Bernstein, C T Fruehan, et al.
Technology in Cancer Research & Treatment|June 21, 2012
Dose escalation with proton radiation therapy for high-grade meningiomasA W Chan, K D Bernstein, J A Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1973
Allograft tolerance: presumptive evidence that serum factors from tolerant animals that block lymphocyte-mediated immunity in vitro are soluble antigen-antibody complexesP W Wright, R E Hargreaves, S C Bansal, et al.
Blood|March 11, 2008
Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenograftsRoland B Walter, Kelli M Boyle, Frederick R Appelbaum, et al.
Journal of the National Cancer Institute|January 15, 1992
Effect of interleukin-2 on biodistribution of monoclonal antibody in tumor and normal tissues in mice bearing SL-2 thymomaK R Schultz, C C Badger, G W Dombi, et al.
Current Opinion in Hematology|July 1, 1995
Targeted therapy for hematologic malignancies: has its promise been realized?D C Matthews, F R Appelbaum, O W Press, et al.
Laryngoscope Investigative Otolaryngology|October 19, 2022
Surgical ergonomics: Assessment of surgeon posture and impact of training device during otolaryngology proceduresKaren L Leung, Rachel M Segal, Jeffrey D Bernstein, et al.
Pageof 73

Showing results (431-440 of 728) with videos related to

Sort By:
Pageof 73
Bone Marrow Transplantation|June 12, 2002
The use of radioimmunoconjugates in stem cell transplantationJ M Pagel, D C Matthews, F R Appelbaum, et al.
The International Journal of the Addictions|March 1, 1995
Methods for assessing drug use prevalence in the workplace: a comparison of self-report, urinalysis, and hair analysisR F Cook, A D Bernstein, T L Arrington, et al.
Cancer Treatment and Research|January 1, 1997
The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignanciesD C Matthews, F R Appelbaum, O W Press, et al.
AJNR. American Journal of Neuroradiology|May 1, 1983
Intravenous digital subtraction angiography with iohexolE D Cacayorin, A D Bernstein, C T Fruehan, et al.
Technology in Cancer Research & Treatment|June 21, 2012
Dose escalation with proton radiation therapy for high-grade meningiomasA W Chan, K D Bernstein, J A Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1973
Allograft tolerance: presumptive evidence that serum factors from tolerant animals that block lymphocyte-mediated immunity in vitro are soluble antigen-antibody complexesP W Wright, R E Hargreaves, S C Bansal, et al.
Blood|March 11, 2008
Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenograftsRoland B Walter, Kelli M Boyle, Frederick R Appelbaum, et al.
Journal of the National Cancer Institute|January 15, 1992
Effect of interleukin-2 on biodistribution of monoclonal antibody in tumor and normal tissues in mice bearing SL-2 thymomaK R Schultz, C C Badger, G W Dombi, et al.
Current Opinion in Hematology|July 1, 1995
Targeted therapy for hematologic malignancies: has its promise been realized?D C Matthews, F R Appelbaum, O W Press, et al.
Laryngoscope Investigative Otolaryngology|October 19, 2022
Surgical ergonomics: Assessment of surgeon posture and impact of training device during otolaryngology proceduresKaren L Leung, Rachel M Segal, Jeffrey D Bernstein, et al.
Pageof 73